Home
PrimeStore MTM (FDA Cleared)
PrimeSeqMDR
PrimeSuite TB
Vaccines
Products
About 
News
More
Intellectual Property
Publications
Contact
PrimeXtract
News
Feb. 24, 2010: Longhorn Vaccines and Diagnostics LLC Receives FDA Emergency Use Authorization (EUA)
 for the First 2009 H1N1 Influenza Assay to Include a Molecular Transport Medium (MTM)
​
Nov. 2, 2015:Longhorn Vaccines and Diagnostics LLC's PrimeSuite TB™ products included in the 2015 UNITAID Tuberculosis Diagnostics Technology and Market Landscape
​
Jul. 20, 2016: 
Tuberculosis Detection With Cepheid MTB Test Improved 
By Longhorn's Sample Transport Medium
May 22, 2017: PrimeStore® Molecular Transport Medium Aiding Laboratories Tracking H7N9 Avian Influenza
​
March 21, 2018: Longhorn Vaccines and Diagnostics LLC receives 
de novo clearance by the U.S. Food and Drug Administration for PrimeStore® Molecular Transport Medium establishing a new class of microbial nucleic acid stabilization devices for molecular testing
​
March 22, 2018: 
World TB Day 2018: US Food and Drug Administration Clears PrimeStore® MTM, an Important New Device
​
September 24, 2018 
Game Changing Tuberculosis Assay Validated for Illumina's MiSeq® Platform
Contact:
jeff@lhnvd.com
301-233-1551
2 Bethesda Metro Center, Suite 910 Bethesda, MD 20814